Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models

Table 2 Characteristics of women with clinical risk factors for pre-eclampsia (PE) who developed PE, by subtype

Maternal Characteristics	Early-onset PE n = 9	Late-onset PE n = 25	p-value*	Severe PE n = 17	Non-severe PE n = 17	p-value*
Age, mean years (SD)	32.4 (4.9)	31.2 (6.1)	0.22	32.6 (5.5)	30.4 (6.0)	0.05
BMI, pre-pregnancy (kg/m²) (SD)	29.5 (8.1)	29.8 (7.1)	0.96	28.0 (7.2)	31.5 (7.1)	0.27
Primiparous, n (%)	2 (22.2)	2 (9.5)	1.00	7 (41.2)	2 (11.8)	0.02
Infertility treatment, n (%)	3 (33.3)	15 (60.0)	1.00	3 (17.6)	1 (7.7)	0.43
Chronic disease, n (%)	5 (56.6)	4 (16.0)	1.00	8 (47.1)	10 (58.8)	0.28

*Binary logistic regression
BMI body mass index, SD standard deviation
Early-onset PE = diagnosed before 34 0/7 weeks of gestation, late-onset PE = diagnosed at or after 34 0/7 weeks of gestation, severe PE = systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mmHg and/or proteinuria ≥5 g/24 h, Non-severe PE = PE not fulfilling the criteria of severe pre-eclampsia

ISSN: 1471-2393